Recent Articles from GlobeNewswire

MUMBAI, India and SANTA CLARA, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a global leader in IT services, consulting, and business solutions, today announced a strategic collaboration with AMD (NASDAQ: AMD) to help enterprises scale AI adoption from pilots to production, modernize legacy environments, and build secure, high performance digital workplaces.

PARIS, FRANCE, 14 JANUARY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the presentation of 14 across multiple neurological conditions at the TOXINS 2026 conference (14-17 January) in Madrid, Spain. Data presented highlighted the depth and diversity of evidence across multiple movement disorders — including post‑stroke spasticity, cervical dystonia and blepharospasm, adding to the available evidence of Dysport®(abobotulinumtoxinA) in patient care – alongside new indications under evaluation.

— First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment —

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report" on Monday, January 12th by Visionary Holdings Inc. (Nasdaq: GV), please be advised that the headline and content have been updated to accurately reflect comments from the U.S. Securities and Exchange Commission. The corrected release follows:

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Klarna Group plc (NYSE: KLAR), if they purchased the Company’s securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Klarna’s September 2025 initial public offering (the “IPO”). This action is pending in the United States District Court for the Eastern District of New York.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in DeFi Technologies Inc. (“DeFi” or the “Company”) (NasdaqCM: DEFT) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Jayud Global Logistics Limited (“Jayud” or the “Company”) (NasdaqCM: JYD) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Bitdeer Technologies Group (“Bitdeer” or the "Company") (NasdaqCM: BTDR), if they purchased or otherwise acquired the Company’s securities between June 6, 2024 and November 10, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR), if they purchased or otherwise acquired the Company’s shares between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE: ARE), if they purchased or otherwise acquired the Company’s securities between January 27, 2025 to October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Sprouts Farmers Market, Inc. (“Sprouts” or the “Company”) (NasdaqGS: SFM), if they purchased or otherwise acquired the Company’s securities between June 4, 2025 and October 29, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company’s securities between October 28, 2024, and October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Washington.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.

NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in securities class action lawsuits against Coupang, Inc. (NYSE: CPNG), if they purchased or otherwise acquired the Company’s securities between May 7, 2025 and December 16, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Courts for the Northern District of California and Western District of Washington.

SINGAPORE, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Bitdeer AI, part of Bitdeer Technologies Group (NASDAQ: BTDR), an emerging AI cloud service provider and NVIDIA Cloud Partner, today announced the launch of its NVIDIA GB200 NVL72 deployment in Malaysia, marking a new chapter in the company’s mission to simplify and scale AI computing globally.

Fujifilm has unveiled the latest addition to their instant camera arsenal with the retro designed Instax mini Evo Cinema. This is the first instant video capable camera in the Instax line and a great 3-in-1 camera for the photo/video enthusiast.

VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) is pleased to announce the appointment of Frank Arcese as Project Director to Donlin Gold LLC (“Donlin Gold”), bringing more than four decades of global project leadership to Donlin Gold. This hiring further strengthens the team as we prepare to launch the work on the Bankable Feasibility Study (BFS) and progress the project toward development.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- ATLAS SP Partners (“ATLAS”), the warehouse finance and securitized products business majority owned by Apollo funds, today announced the pricing of an offering of $500 million in aggregate principal amount of additional 4.625% senior notes due 2028 (the “Add-On Notes”) and $750 million in aggregate principal amount of 5.250% senior notes due 2033 (the “New Notes” and, together with the Add-On Notes, the “Notes”) by Atlas Warehouse Lending Company, L.P. (“AWLC”) in a private offering under Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”) to eligible purchasers (the “Offering”).

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Klarna Group plc (“Klarna” or the “Company”) (NYSE:KLAR) investors of the February 20, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Jayud Global Logistics Limited (“Jayud” or the “Company”) (NYSE:JYD) investors of the January 20, 2026 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Jayud securities between April 21, 2023 through April 30, 2025 (“the Class Period”).         Follow the link below for more information:

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, today announced that it has taken up and paid for 2,855,696 of its common shares (“Shares”) at a price of C$57.00 per Share (the “Purchase Price”) under Altus Group’s substantial issuer bid (the “SIB”) to repurchase for cancellation a number of its Shares for an aggregate purchase price not to exceed C$350 million.

SUNNYVALE, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- eGain Corporation (NASDAQ: EGAN), the leading AI knowledge platform for customer service, today announced that SELCO Community Credit Union has selected the eGain AI Knowledge Hub and AI Agent software to modernize its enterprise knowledge management and empower employees across the organization.

CHICAGO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Amplify ETFs today announced that the net asset value (NAV) of the Amplify BlackSwan Growth & Treasury Core ETF (SWAN) was decreased by $1.2713 per share on Friday, Jan. 9, 2026. This adjustment is a result of a security pricing error in calculating the Fund’s NAV.

RESTON, VA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its second quarter fiscal year 2026 financial results during a conference call scheduled for Tuesday, January 27, 2026 at 5:00 p.m. eastern time (ET). 

BROOKFIELD, News, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Brookfield Renewable (NYSE: BEP, BEPC; TSX: BEP.UN, BEPC) (“Brookfield Renewable”) today announced that it has agreed to issue C$500 million aggregate principal amount of Series 20 Notes (the “Notes”), due January 15, 2056, which will bear interest at a rate of 5.204% per annum.

QUÉBEC CITY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Robex Resources Inc. (“Robex” or the “Company”) is pleased to announce it has obtained a final order from the Québec Superior Court (Commercial Division) approving the previously announced merger with Predictive Discovery Limited (“Predictive”) pursuant to which Predictive, through its direct wholly-owned subsidiary, will acquire all of the issued and outstanding common shares of Robex (“Robex Shares”) by way of a statutory plan of arrangement under the Business Corporations Act (Québec) (“Arrangement”).

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

ST. LOUIS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) today announced it will release its financial results for the first quarter of fiscal year 2026 and its fiscal year 2026 outlook on February 3, 2026 at 7:00 a.m. ET. The release will be followed by a conference call at 8:30 a.m. ET to discuss the results and outlook. Darcy H. Davenport, President and Chief Executive Officer, and Paul A. Rode, Chief Financial Officer, will participate in the call.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

RONAN, Mont., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AIRJ” or the “Company”) today announced the commencement of an underwritten public offering of shares of its Class A common stock, par value $0.0001 per share (“Class A common stock”), pursuant to an effective shelf registration statement on Form S-3 (File No. 333-291527) (the “Registration Statement”) previously filed with the U.S. Securities and Exchange Commission (the “SEC”). The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Air Products and Chemicals, Inc. (“Air Products” or the “Company”) (NYSE: APD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. (“SNDL” or the “Company”) (NASDAQ: SNDL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Above Foods Ingredients Inc. (“Above Food” or the “Company”) (NASDAQ: ABVE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Graphic Packaging Holding Company (“Graphic Packaging” or the “Company”) (NYSE: GPK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  LENZ Therapeutics, Inc. (“LENZ” or the “Company”) (NASDAQ: LENZ).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ: LAKE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The new daily REVIVE series “JAY WALKER” airs at 7:00 PM ET and delivers conversation + tools in a purpose-driven format

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation (“Xoma” or the “Company”) (NASDAQ: XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ: METC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rezolute, Inc. (“Rezolute” or the “Company”) (NASDAQ: RZLT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. (“Aerovironment” or the “Company”) (NASDAQ: AVAV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Chicago, January 13, 2026, Jan. 13, 2026 (GLOBE NEWSWIRE) -- North Park University (NPU) has received an $8,184,203 grant from Lilly Endowment Inc. for its seminary, North Park Theological Seminary, to launch One Covenant Community, a collaborative project that aims to cultivate pastoral leadership across the Evangelical Covenant Church (ECC) by strengthening vocational discernment, theological education, credentialing, and lifelong support.  

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ETHZilla Corporation (“ETHZilla” or the “Company”) (NASDAQ: ETHZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

A search to name a successor is currently underway

BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced the appointment of world-renowned neurologist and epilepsy authority Dr. Orrin Devinsky, M.D., as Head of Clinical Strategy, a newly created leadership role.

MCLEAN, Va., Jan. 13, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced its Mission Technologies division was awarded a contract for the Missile Defense Agency Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) indefinite-delivery/indefinite-quantity (IDIQ) contract with a ceiling of $151 billion.

Conference Call Scheduled for 8:00 a.m. ET on February 12th, 2026

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Galectin Therapeutics Inc. (“Galectin” or the “Company”) (NASDAQ: GALT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated (“Insmed” or the “Company”) (NASDAQ: INSM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

DETROIT, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Alpine IQ (AIQ), the leading data and marketing platform for cannabis retailers and brands, today announced a major evolution of its Loops media product: direct-to-menu destination URLs that route every brand impression to the appropriate retailer’s menu, brand page, or product page.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Duluth Holdings Inc. (“Duluth” or the “Company”) (NASDAQ: DLTH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cogent Communications Holdings, Inc.  (“Cogent” or the “Company”) (NASDAQ: CCOI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

PERRYSBURG, Ohio, Jan. 13, 2026 (GLOBE NEWSWIRE) -- O-I Glass, Inc. (NYSE: OI) has scheduled its full year and fourth quarter 2025 conference call and webcast for Wednesday, February 11, 2026, at 8 a.m. EST. The Company’s news release for the full year and fourth quarter 2025 earnings will be issued after the market closes on Tuesday, February 10.

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)

WILMINGTON, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of UniFirst Corporation (NYSE:UNF) today declared regular quarterly cash dividends of $0.365 per share (36.5 cents) on the Company's Common Stock and $0.292 per share (29.2 cents) on the Company's Class B Common Stock. Both dividends are payable on March 27, 2026 to shareholders of record on March 6, 2026.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ: NUAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bgin Blockchain Limited (“Bgin” or the “Company”) (NASDAQ: BGIN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. (“Nutanix” or the “Company”) (NASDAQ: NTNX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

WATERTOWN, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced the closing of its $50 million registered direct financing at a 30% premium. The registered direct offering included the sale of 2,030,314 shares of common stock at $6.71 per share (issue price). Certain investors received pre-funded warrants to purchase up to 5,421,250 shares at $6.7099 each, which reflects the share price minus a nominal exercise cost of $0.0001 per share. The offering also included series warrants to buy up to 3,725,782 shares at $13.42 per share (2x issue price) and another 3,725,782 shares at $20.13 per share (3x issue price). The $6.71 purchase price represented a 30% premium over the Nasdaq Global Market price on January 9, 2026. All shares in the offering were sold by Foghorn. The gross proceeds from the offering were approximately $50 million (excluding any proceeds to be received upon exercise of the series warrants).

WALTHAM, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, today announced its schedule for the company’s fourth quarter and full year 2025 results.

CHICAGO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) will release its fourth quarter 2025 financial results on Tuesday, February 03, 2026, at 4:05 p.m. ET and will host a conference call at 5:00 p.m. ET that day.Investors and analysts may participate via phone by calling 800-245-3047 from the United States and 203-518-9765 from other locations. To ensure timely access, participants should dial in approximately 10 minutes before the call starts. A listen-only webcast will be provided at www.mondelezinternational.com.A replay of the conference call will be available until February 10, 2026, by calling 800-839-9302 from the United States and 402-220-6082 from other locations. The access code for both the conference call and its rebroadcast is MDLZQ425. An archive of the webcast will be available on the company's website.About Mondelēz InternationalMondelēz International, Inc. (Nasdaq: MDLZ) empowers people to snack right in over 150 countries around the world. With 2024 net revenues of approximately $36.4 billion, MDLZ is leading the future of snacking with iconic global and local brands such as Oreo, Ritz, LU, Clif Bar and Tate's Bake Shop biscuits and baked snacks, as well as Cadbury Dairy Milk, Milka and Toblerone chocolate. Mondelēz International is a proud member of the Dow Jones Best-in-Class North America and World Indices, formerly Dow Jones Sustainability Indices. Visit www.mondelezinternational.com or follow the company on X at x.com/MDLZ.